1. Home
  2. INTS vs AWRE Comparison

INTS vs AWRE Comparison

Compare INTS & AWRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTS
  • AWRE
  • Stock Information
  • Founded
  • INTS 2012
  • AWRE 1986
  • Country
  • INTS United States
  • AWRE United States
  • Employees
  • INTS N/A
  • AWRE N/A
  • Industry
  • INTS Biotechnology: Pharmaceutical Preparations
  • AWRE Computer Software: Prepackaged Software
  • Sector
  • INTS Health Care
  • AWRE Technology
  • Exchange
  • INTS Nasdaq
  • AWRE Nasdaq
  • Market Cap
  • INTS 8.0M
  • AWRE 34.6M
  • IPO Year
  • INTS 2023
  • AWRE 1996
  • Fundamental
  • Price
  • INTS $0.33
  • AWRE $2.21
  • Analyst Decision
  • INTS Strong Buy
  • AWRE
  • Analyst Count
  • INTS 3
  • AWRE 0
  • Target Price
  • INTS $8.50
  • AWRE N/A
  • AVG Volume (30 Days)
  • INTS 3.7M
  • AWRE 62.6K
  • Earning Date
  • INTS 08-07-2025
  • AWRE 08-07-2025
  • Dividend Yield
  • INTS N/A
  • AWRE N/A
  • EPS Growth
  • INTS N/A
  • AWRE N/A
  • EPS
  • INTS N/A
  • AWRE N/A
  • Revenue
  • INTS N/A
  • AWRE $16,576,000.00
  • Revenue This Year
  • INTS N/A
  • AWRE N/A
  • Revenue Next Year
  • INTS N/A
  • AWRE N/A
  • P/E Ratio
  • INTS N/A
  • AWRE N/A
  • Revenue Growth
  • INTS N/A
  • AWRE N/A
  • 52 Week Low
  • INTS $0.26
  • AWRE $1.35
  • 52 Week High
  • INTS $5.10
  • AWRE $2.97
  • Technical
  • Relative Strength Index (RSI)
  • INTS 41.29
  • AWRE 74.91
  • Support Level
  • INTS $0.26
  • AWRE $1.78
  • Resistance Level
  • INTS $0.32
  • AWRE $1.93
  • Average True Range (ATR)
  • INTS 0.03
  • AWRE 0.12
  • MACD
  • INTS 0.02
  • AWRE 0.03
  • Stochastic Oscillator
  • INTS 62.56
  • AWRE 80.00

About INTS Intensity Therapeutics Inc. Common stock

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

Share on Social Networks: